These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1891848)

  • 21. [Hemodynamic effects of amrinone and comparison with dobutamine in patients with chronic respiratory insufficiency with pulmonary hypertension].
    Faitg R; Coulaud JM; Rezgui N; Brulot N; Clavier H; Besse B; Labrousse J; Lissac J
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):333-7. PubMed ID: 2757350
    [No Abstract]   [Full Text] [Related]  

  • 22. [24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril].
    Ol'binskaia LI; Belov AA
    Ter Arkh; 2002; 74(3):59-62. PubMed ID: 11980126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of essential hypertension with captopril in patients with chronic obstructive pulmonary disease.
    Bertoli L; Fusco M; Micallef E; Busnardo I
    J Hypertens Suppl; 1985 Nov; 3(2):S153-4. PubMed ID: 3910774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between airway resistance FEV 1.0 and viscous work of breathing in patients with chronic obstructive lung disease before and after bronchodilation.
    Quanjer PH; Hilvering C; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1971; 7(3):539-54. PubMed ID: 5119274
    [No Abstract]   [Full Text] [Related]  

  • 26. [Foridon in the combined treatment of patients with chronic obstructive lung diseases].
    Mikunis RI; Demidiuk VT
    Vrach Delo; 1990 Apr; (4):68-9. PubMed ID: 2275174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilators and chronic obstructive pulmonary disease.
    Singh A
    N Z Med J; 1997 Aug; 110(1049):300. PubMed ID: 9293287
    [No Abstract]   [Full Text] [Related]  

  • 29. COPD. Assessing functional status.
    Daly WJ
    Hosp Pract (Off Ed); 1985 Mar; 20(3A):73-7, 82-5, 89-93. PubMed ID: 3932414
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemodynamic and respiratory effects of phentolamine in pulmonary hypertension secondary to chronic obstructive syndrome].
    Domenighetti G; Leuenberger P; Perret C
    Schweiz Med Wochenschr; 1985 Jan; 115(3):99-103. PubMed ID: 3975579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic changes and their relationship with the renin-angiotensin-aldosterone system in chronic obstructive pulmonary disease].
    Zen GB
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):311-4, 22. PubMed ID: 2679985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxygen saturation during sleep in chronic obstructive lung diseases before and after bronchodilator therapy. A controlled, prospective study in 36 patients].
    Schmid T; Dreher D; Karrer W
    Schweiz Med Wochenschr; 1988 Nov; 118(45):1645-50. PubMed ID: 3187481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single versus multiple aerosol bronchodilator dosage in chronic obstructive pulmonary disease.
    Russakoff AH; Russakoff AD; Grimley KW
    Ala J Med Sci; 1974 Jul; 11(3):252-6. PubMed ID: 4451264
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of adequate therapy on the indices of external respiratory function in patients with arterial hypertension combined with obstructive lung diseases].
    Katiukhin VN; Sinitsina TM
    Ter Arkh; 1990; 62(3):75-8. PubMed ID: 2368003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of verapamil in the treatment of hypertension.
    Anavekar SN; Doyle AE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):90S-99S. PubMed ID: 3540229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)].
    Sclavo M; Bucca C; Rolla G; Borello G; Balbi L; Angelino PF
    G Ital Cardiol; 1981; 11(5):634-42. PubMed ID: 7286534
    [No Abstract]   [Full Text] [Related]  

  • 39. [Aterial hypertension and coronary heart disease in patients with chronic obstructive lung disease].
    Tidsskr Nor Laegeforen; 1976 Oct; 96(29):1539-41. PubMed ID: 982384
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Frangulian RR
    Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.